Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Canakinumab Side Effects

Common Side Effects

Canakinumab has been studied extensively in clinical trials. In these studies, the side effects that occurred in a group of people who received the drug were carefully documented, so it was possible to see what side effects occurred and how often they appeared.
 
In these studies, the most common side effects of canakinumab included but were not limited to:
 
  • An infection (of any type) -- in up to 54.8 percent of people
  • Symptoms of the common cold -- up to 34 percent
  • Diarrhea -- up to 20 percent
  • The flu (influenza) -- up to 17 percent
  • A runny nose -- up to 17 percent
  • Stomach pain (abdominal pain) -- up to 16 percent
  • Nausea -- up to 14 percent
  • Headache -- up to 14 percent
  • Skin reaction at the injection site – up to 12 percent
  • Coughing -- up to 11 percent
  • Vomiting -- up to 11 percent
  • Sore throat -- up to 11 percent
  • Weight gain -- up to 11 percent
  • Pain -- up to 11 percent
  • Whirling or spinning sensations (vertigo) -- up to 11 percent.
 

Final Thoughts

You may experience some or none of the canakinumab side effects listed in this article. Unfortunately, there is no way for your healthcare provider to know beforehand if you will have problems with a medicine that you have never tried.
 
Therefore, make sure to let your healthcare provider know if you develop any side effects while using canakinumab or if something "just does not seem right." While it may not be related to the medication, your healthcare provider will be able to diagnose and treat the problem.
Type 2 Diabetes: Fact or Fiction

Canakinumab Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.